First Wave Bio Investors Sue In Del. For AzurRx Merger Money
Former shareholders of biopharmaceutical company First Wave Bio Inc., which merged with AzurRx BioPharma Inc. in 2021, sued the company in Delaware Chancery Court on Thursday, saying it had refused to...To view the full article, register now.
Already a subscriber? Click here to view full article